Elevated levels of soluble CD8 antigen in sera of patients with psoriasis — a possible sign of suppressor/cytotoxic T-cell activation
✍ Scribed by A. Kapp
- Publisher
- Springer-Verlag
- Year
- 1990
- Tongue
- English
- Weight
- 184 KB
- Volume
- 282
- Category
- Article
- ISSN
- 0340-3696
No coin nor oath required. For personal study only.
✦ Synopsis
Increased levels of the soluble CD8 antigen probably represent a sign of suppressor T-cell activity. The concentration of CD8 was measured in the sera of patients with psoriasis without psoriatic arthritis (n = 25) and atopic dermatitis (n = 26), exhibiting moderate to severe disease activity, in comparison with nonatopic healthy controls (n = 31) using an ELISA technique. CD8 levels were found to be significantly elevated in psoriatic patients as compared with healthy controls (p less than or equal to 0.002). Increase in CD8 may be due to suppressor T-cell activation in the skin of patients with psoriasis.
📜 SIMILAR VOLUMES
Objective. Bone marrow stromal cell antigen I (BST-1) is a novel glycosyl phosphatidylinositolanchored ectoenzyme, which is overexpressed on bone marrow stromal and synovial cell lines derived from patients with rheumatoid arthritis (RA). To investigate the pathophysiologic roles of BST-I in RA, we
Using a sandwich enzyme-linked immunosorbent assay (ELISA) we were able to detect a soluble form of the CD30 antigen (CD30s) in the supernatant of cell lines expressing membrane-bound CD30 and in T and B cells after transformation with human T-cell leukemia virus (HTLV-I) and Epstein-Barr-Virus (EBV